Olof
Solin
Turku PET Centre
Senior Advisor, Turku PET Centre
Contact
Publications
PET imaging and ex vivo brain autoradiography in a mouse model of Alzheimers disease using the TSPO tracers [F-18]DPA-714 and [F-18]F-DPA (2015)
Journal of Labelled Compounds and Radiopharmaceuticals
(Muu (O2))
Electrophilic fluorination and preclinical evaluation of a novel [F-18]DPA-714 analogue, [F-18]F-DPA (2015)
Journal of Labelled Compounds and Radiopharmaceuticals
(Muu (O2))
Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [(18)F]FEMPA in Alzheimer's disease patients and control subjects. (2015)
European Journal of Nuclear Medicine and Molecular Imaging
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Organomediated Enantioselective 18F-Fluorination for PET Applications (2015)
Angewandte Chemie International Edition
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Anti-VLA-4 treatment reduces microglial activation in a focal EAE-model (2015)
Glia
(Muu (O2))
Imaging mitochondrial membrane potential using a novel F-18-labeled BMS derivative (F-18-FP10X) (2015)
Journal of Nuclear Medicine
(Muu (O2))
Amphetamine Decreases α2C-Adrenoceptor Binding of [11C]ORM-13070 - A PET Study in the Primate Brain (2015)
International Journal of Neuropsychopharmacology
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
The Cannabinoid Receptor-1 Is an Imaging Biomarker of Brown Adipose Tissue. (2015)
Journal of Nuclear Medicine
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Quantification of [F-18]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients (2015)
Journal of Cerebral Blood Flow and Metabolism
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Intricacies of F-18-labelling of exendin-4 via click chemistry (2015)
Journal of Labelled Compounds and Radiopharmaceuticals
(Muu (O2))